Literature DB >> 12040173

TNF-R1 signaling: a beautiful pathway.

Guoqing Chen1, David V Goeddel.   

Abstract

Tumor necrosis factor (TNF) is a major mediator of apoptosis as well as inflammation and immunity, and it has been implicated in the pathogenesis of a wide spectrum of human diseases, including sepsis, diabetes, cancer, osteoporosis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel diseases. The interaction of TNF with TNF receptor-1 (TNF-R1) activates several signal transduction pathways. A common feature of each pathway is the TNF-induced formation of a multiprotein signaling complex at the cell membrane. Over the past decade, many of the components and mechanisms of these signaling pathways have been elucidated. We provide an overview of current knowledge of TNF signaling and introduce an STKE Connections Map that depicts a canonical view of this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040173     DOI: 10.1126/science.1071924

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  574 in total

1.  TRUSS, TNF-R1, and TRPC ion channels synergistically reverse endoplasmic reticulum Ca2+ storage reduction in response to m1 muscarinic acetylcholine receptor signaling.

Authors:  Kimberly E Mace; Marc P Lussier; Guylain Boulay; Jennifer L Terry-Powers; Helen Parfrey; Anne-Laure Perraud; David W H Riches
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

2.  Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.

Authors:  Anna Simon; Heiyoung Park; Ravikanth Maddipati; Adrian A Lobito; Ariel C Bulua; Adrianna J Jackson; Jae Jin Chae; Rachel Ettinger; Heleen D de Koning; Anthony C Cruz; Daniel L Kastner; Hirsh Komarow; Richard M Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 3.  The phenotypic and functional consequences of tumour necrosis factor receptor type 2 expression on CD4(+) FoxP3(+) regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 4.  Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

5.  Mitochondrial Ca²+ and ROS take center stage to orchestrate TNF-α-mediated inflammatory responses.

Authors:  Laura A Dada; Jacob I Sznajder
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

Review 6.  Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture.

Authors:  Robert M Starke; Daniel M S Raper; Dale Ding; Nohra Chalouhi; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-09-20       Impact factor: 6.829

7.  Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Authors:  Ping La; Yuqing Yang; Satyajit K Karnik; Albert C Silva; Robert W Schnepp; Seung K Kim; Xianxin Hua
Journal:  J Biol Chem       Date:  2007-08-31       Impact factor: 5.157

8.  Menin induces apoptosis in murine embryonic fibroblasts.

Authors:  Robert W Schnepp; Hua Mao; Stephen M Sykes; Wei-Xing Zong; Albert Silva; Ping La; Xianxin Hua
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

9.  Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.

Authors:  Ping Hu; Zhang Han; Anthony D Couvillon; Randal J Kaufman; John H Exton
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.

Authors:  Marzenna Blonska; Yun You; Romas Geleziunas; Xin Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.